Differing T-cell requirements for recombinant retrovirus vaccines (original) (raw)
Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge
Martin Lavin
Nature Medicine, 1998
View PDFchevron_right
Protection against retroviral diseases after vaccination is conferred by interference to superinfection with attenuated murine leukemia viruses
Marc Sitbon
Journal of virology, 1993
View PDFchevron_right
Interference of retroviral envelope with vaccine-induced CD8+ T cell responses is relieved by co-administration of cytokine-encoding vectors
Wibke Bayer
Retrovirology
View PDFchevron_right
Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines
Suzanne L Elliott
European Journal of Immunology, 2000
View PDFchevron_right
Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease
Masaaki Miyazawa
International Immunology, 2005
View PDFchevron_right
Activation conditions determine susceptibility of murine primary T‐lymphocytes to retroviral infection
Cuiwen Tan
The Journal of Gene …, 1999
View PDFchevron_right
Retroviral immunology: lessons from a mouse model
Kim Hasenkrug
Immunologic Research, 2009
View PDFchevron_right
Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development
Masaaki Miyazawa
Journal of Immunology, 1995
View PDFchevron_right
Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection
Wibke Bayer
PLOS Pathogens
View PDFchevron_right
Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus)
Mirdad Kazanji
Journal of General Virology, 2006
View PDFchevron_right
Retroviral vector backbone immunogenicity: identification of cytotoxic T-cell epitopes in retroviral vector-packaging sequences
carlos irigoyen
Gene Therapy, 2004
View PDFchevron_right
Clonotypic Composition of the CD4+ T Cell Response to a Vectored Retroviral Antigen Is Determined by Its Speed
Kim Hasenkrug
The Journal of Immunology, 2014
View PDFchevron_right
Identification of a Protective CD4 + T-Cell Epitope in p15 gag of Friend Murine Leukemia Virus and Role of the MA Protein Targeting the Plasma Membrane in Immunogenicity
Masaaki Miyazawa
Journal of Virology, 2004
View PDFchevron_right
Vaccine Targeting of Subdominant CD8+ T Cell Epitopes Increases the Breadth of the T Cell Response upon Viral Challenge, but May Impair Immediate Virus Control
Jan Christensen
Journal of immunology (Baltimore, Md. : 1950), 2016
View PDFchevron_right
Novel Role of CD8+ T Cells and Major Histocompatibility Complex Class I Genes in the Generation of Protective CD4+ Th1 Responses during Retrovirus Infection in Mice
K. Hasenkrug
Journal of Virology, 2002
View PDFchevron_right
Identification of a Protective CD4+ T-Cell Epitope in p15gag of Friend Murine Leukemia Virus and Role of the MA Protein Targeting the Plasma Membrane in Immunogenicity
Masaaki Miyazawa
Journal of Virology, 2004
View PDFchevron_right
Role of T cell competition in the induction of cytotoxic T lymphocyte activity during viral vector-based immunization regimens
Toos Daemen
Vaccine, 2010
View PDFchevron_right
In Vivo Induction of a High-Avidity, High-Frequency Cytotoxic T-Lymphocyte Response Is Associated with Antiviral Protective Immunity
Marie Rojas
Journal of Virology, 2000
View PDFchevron_right
Vaccination against δ-Retroviruses: The Bovine Leukemia Virus Paradigm
Karina Trono
Viruses, 2014
View PDFchevron_right
Immune suppression of vaccine-induced CD8+ T-cell responses by gamma retrovirus envelope is mediated by interleukin-10-producing CD4+ T cells
Wibke Bayer
Frontiers in Immunology, 2022
View PDFchevron_right
Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 mice
Martin Kast
Journal of Virology, 1994
View PDFchevron_right
“Negative Vaccination” by Specific CD4+ T Cell Tolerisation Enhances Virus-Specific Protective Antibody Responses
Ahmed Hegazy
PLoS ONE, 2007
View PDFchevron_right
Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model
Wibke Bayer
Retrovirology, 2011
View PDFchevron_right
Role of regulatory T-cells in immunization strategies involving a recombinant alphavirus vector system
Toos Daemen
Antiviral Therapy, 2011
View PDFchevron_right
Vaccination with an Adenoviral Vector That Encodes and Displays a Retroviral Antigen Induces Improved Neutralizing Antibody and CD4+ T-Cell Responses and Confers Enhanced Protection
Wibke Bayer
Journal of Virology, 2010
View PDFchevron_right
Handling of retroviral antigens by human antigen-presenting cells
Francesca Buffa
Research in Virology, 1996
View PDFchevron_right
Protective Efficacy of Multiepitope Human Leukocyte Antigen???A*0201 Restricted Cytotoxic T-Lymphocyte Peptide Construct Against Challenge With Human T-Cell Lymphotropic Virus Type 1 Tax Recombinant Vaccinia Virus
Pravin Kaumaya
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
View PDFchevron_right
Protection against Lethal Cytomegalovirus Infection bya Recombinant Vaccine Containing a Single Nonameric T-Cell Epitope
Matthias Reddehase
2000
View PDFchevron_right
Immunodominance of Adenovirus-Derived CD8+ T Cell Epitopes Interferes with the Induction of Transgene-Specific Immunity in Adenovirus-Based Immunization
Wibke Bayer
Journal of virology, 2017
View PDFchevron_right
Retroviral transduction of T-cell receptors in mouse T-cells
Michelle Krogsgaard
Journal of visualized experiments : JoVE, 2010
View PDFchevron_right